September 19, 2024 C-Path’s PKD Outcomes Consortium Receives BAA Award for Project to Advance Drug Development Tools for Autosomal Dominant Tubulointerstitial Kidney Disease C-Path is thrilled to announce its PKDOC has been awarded...
September 12, 2024 Steve Gleason Welcomes Guests to Day 2 of #CGIC24 Former NFL player and ALS patient advocate welcomes attendees to the second day of C-Path’s Global Impact Conference.
September 12, 2024 C-Path’s Inaugural Global Impact Conference Charts the Future of Drug Development C-Path successfully concluded its inaugural Global Impact Conference (CGIC) on September 11, 2024.
September 9, 2024 FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials in Parkinson’s and Related Diseases FDA) encouraged scientists and drug developers to use the alpha-synuclein seed amplification assay (αSyn-SAA) biomarker...
September 5, 2024 Cystic Fibrosis Therapeutics Development Network Contributes New Data Sets to C-Path’s RDCA-DAP, Advancing CF Research and Treatment Strategies Critical Path Institute (C-Path) today announced the addition of significant new data sets...
October 1, 2024-October 2, 2024 Join C-Path at the Health Research Alliance Fall Conference C-Path's Maaike Everts, PhD, Executive Director of its Translational Therapeutics Accelerate (TRxA), is participating in...
October 23, 2024-October 27, 2024 American Society of Nephrology (ASN) Kidney Week 2024 BmDR Oversight Committee members Nicholas King, Katrina Peron, and Gary Friedman will be attending ASN Kidney Week 2024 in San..
August 30, 2024 C-Path Announces FDA Commissioner Robert Califf to Participate in Opening Session at Inaugural Global Impact Conference C-Path is honored to announce that FDA Commissioner Robert M. Califf, M.D., MACC, will participate as a panelist...
August 22, 2024 C-Path Awarded $1.5 Million Grant from Ara Parseghian Medical Research Fund at Notre Dame to Enhance Collaboration in Niemann-Pick Disease Research and Drug Development C-Path is thrilled to announce its CPLD Consortium has been awarded a grant from the Ara Parseghian...
August 22, 2024 C-Path’s TRxA Announces $250,000 Grant for Drug Development Project in Prostate Cancer C-Path proudly announced today a $250,000 grant award to Peter Wipf, Ph.D...